COURNOYER CHRISTINE sold $751K of CDNA

COURNOYER CHRISTINE sold 16,000 shares of CareDx, Inc. (CDNA) at $46.94 ($0.75M total) on 2026-08-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · COURNOYER CHRISTINE
Published Aug 6, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 7:41 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CDNA
Neutral
high confidence
Mentioned
$CDNA
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CDNANeutralLow
01

Why it matters

The newest fact is the director’s sale size, price, and total proceeds, executed on 2026-08-04 and reported on 2026-08-06.

02

Market read

This is a routine insider sale disclosure with no accompanying operational or guidance update.

03

What to watch

Traders may overreact to insider sales; the key missing detail is whether other insiders or the company simultaneously disclosed new fundamentals, which this filing does not provide.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-06, sale dated 2026-08-04

Background

The article is an SEC Form 4 insider transaction disclosure for CareDx, Inc. (CDNA).

Company-level read

Ticker impact

$CDNANeutralHigh confidence
Context

CareDx director COURNOYER CHRISTINE sold 16,000 shares of CDNA for about $750,973 under a pre-arranged 10b5-1 plan.

Expected impact

Limited immediate impact expected; any effect is likely sentiment-only and short-lived.

Evidence & confidence

The filing is a routine Form 4 insider sale with stated 10b5-1 pre-arrangement, and it does not include new company operating or financial information.

Market effects

No clear sector read-through from a single director 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Because the sale is pre-arranged under 10b5-1, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • CareDx, Inc.

    Company whose shares were sold by a director under a 10b5-1 plan.

  • COURNOYER CHRISTINE

    Director who sold 16,000 shares of CDNA at $46.9358 per share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CRWVMed

Futures Rise As CoreWeave Calms Debt Jitters, Sparking AI Rebound; Oil Jumps On Hormuz Mines

US futures rise as CoreWeave (CRWV) boosts its revenue forecast, easing debt concerns. AI sector gains momentum with reports of Anthropic's potential $1.5T IPO and OpenAI's $10B quarterly revenue. Nasdaq futures recover Tuesday's losses, while Treasuries near 5% on 10Y. Oil jumps on Strait of Hormuz tensions. CoreWeave shares up 15% premarket. NVDA +5.1%, TSLA +2%, GOOGL +1.2%.

$CDNALow

Why CareDx Stock Soared Today

CareDx (CDNA) shares rose 22% after Q3 revenue surged 39% YoY to $139M, driven by 65% growth in testing services. Testing volumes increased 51% to 75,900, aided by the Naveris acquisition. EBITDA doubled to $30M. The company raised full-year revenue guidance to $525M and adjusted EBITDA targets to $90M-$100M, citing growing interest in precision medicine diagnostics.

$CDNAHighAI 8/10

CareDx Soars 20% on Big Q3 Beat and Guidance Raise

CareDx's shares rose 20% after Q3 revenue increased 39% to $139M, surpassing expectations. The company raised 2026 revenue guidance to $520M-$530M. Adjusted EBITDA doubled to $30M. Natera, a competitor, reports next week, which may indicate market growth or share shifts.